This is a standard initial ownership filing and should not be interpreted as a trading signal. Traders should monitor future Form 4 filings for actual option exercises or share transactions by Hite.
Price Chart
Executive Summary
Christopher Davis Hite, a reporting person at Kailera Therapeutics (KLRA), filed a Form 3 disclosing initial ownership of stock options and granting a power of attorney to three individuals to file required SEC reports on his behalf. This is a routine initial filing for a new insider and does not reflect any change in ownership or corporate event.
Key Facts
- Christopher Davis Hite filed a Form 3, indicating initial reporting of beneficial ownership of KLRA securities.
- The filing discloses two stock option grants: 81,048 shares at $5.40 strike price expiring 2035-06-03, and 89,146 shares at $7.24 strike price expiring 2035-11-05.
- Options vest 25% on first anniversary and in 36 equal monthly installments thereafter, subject to continued service.
- Hite granted a power of attorney to Scott Akamine, John Mei, and Corey Manchester to file SEC reports (Forms 3, 4, 5, 144, etc.) on his behalf.
- The filing is administrative in nature and does not indicate any actual purchase or sale of shares.
Financial Impact
No immediate financial impact. The options represent future equity exposure, but no dilution or cash flow impact is triggered by this filing.
Risk Factors
- Misinterpretation of the filing as a positive signal due to option disclosure, when it is merely a regulatory requirement.
- Future insider selling could create downward pressure, but no such activity is indicated here.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-159665 |
| Document: 0001193125-26-159665-index-headers.html | 0001193125-26-159665 |
| Document: 0001193125-26-159665-index.html | 0001193125-26-159665 |
| Document: 0001193125-26-159665.txt | 0001193125-26-159665 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 3 | $14.91 $12.92 | ▼ −13.35% | ▼ −12.85% | $10.39 (−30.32%) |
Aug 12, 2026 7w ago | 8-K | $17.97 $17.47 | ▼ −2.78% | ▼ −0.82% | $10.39 (−42.18%) |
Jul 31, 2026 9w ago | Court Ruling | $16.94 $18.66 | ▲ +10.15% | ▲ +6.64% | $10.39 (−38.67%) |
Jul 24, 2026 10w ago | Court Ruling | $17.69 $17.05 | ▼ −3.62% | ▼ −3.99% | $10.39 (−41.27%) |
Jun 5, 2026 16w ago | Press Release | $19.70 $19.67 | ▼ −0.15% | ▼ −2.26% | $10.39 (−47.26%) |
May 26, 2026 18w ago | 8-K | $21.91 $22.38 | ▲ +2.15% | ▲ +1.68% | $10.39 (−52.58%) |
May 26, 2026 18w ago | Press Release | $21.91 $22.59 | ▲ +3.10% | ▲ +1.90% | $10.39 (−52.58%) |
May 13, 2026 20w ago | Press Release | $21.11 $19.62 | ▼ −7.06% | ▼ −5.90% | $10.39 (−50.78%) |
Apr 20, 2026 23w ago | 8-K | $25.22 $23.82 | ▼ −5.55% | ▼ −6.63% | $10.39 (−58.80%) |
Apr 20, 2026 23w ago | Insider Cluster | $24.61 $23.51 | ▼ −4.47% | ▼ −5.38% | $10.39 (−57.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access